MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s13760-023-02190-5

Медицинская библиотека · Acta neurologica Belgica · 2023

Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study.

Guerzoni Simona, Baraldi Carlo, Brovia Daria, Cainazzo Maria Michela, Castro Flavia Lo, Pani Luca

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Migraine usually ameliorates after menopause. However, 10-29% of women still experience migraine attacks after menopause, especially if menopause is surgical. The use of monoclonal antibodies against the calcitonin gene-related peptide (CGRP) is changing the landscape of migraine treatment. This study aims to explore the effectiveness and safety of anti-CGRP monoclonal antibodies in women in menopause.

METHODS

Women affected by either migraine or chronic migraine and treated with an anti-CGRP monoclonal antibody for up to 1 year. Visits were scheduled every 3 months.

RESULTS

Women in menopause displayed a similar response compared to women of childbearing age. Among women in menopause, the women experiencing surgical menopause seemed to exhibit a similar response compared to the ones experiencing physiological menopause. Erenumab and galcanezumab displayed similar effectiveness in women in menopause. No serious adverse events were registered.

DISCUSSION: The effectiveness of anti-CGRP monoclonal antibodies is almost the same between women in menopause and women of childbearing age, without appreciable differences between the different antibodies.

Для цитирования: Guerzoni Simona, Baraldi Carlo, Brovia Daria, Cainazzo Maria Michela, Castro Flavia Lo, Pani Luca. Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study.. Acta neurologica Belgica. 2023. DOI: 10.1007/s13760-023-02190-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.